ARCHIVES

Broder To Leave In March; Sondik To Be Acting Director

This article is from The Cancer Letter archive.

Vol. 21 No. 04 | January 27, 1995

Download PDF Visit The Full Archive

Related Articles

Possible Budget Balancing Effort Darkens Prospect For Increase In Cancer Budget

March 7, 1980

Aranesp Study Finds No Difference In Survival Or Progression In Small-Cell Lung Cancer.

April 20, 2007

New Year Sees Growing Attacks On Cancer Program; Critics Repeat Untrue Charges, OMB Continues

January 3, 1975

EntreMed Begins Phase I/II Trial For Endostatin.

July 27, 2001

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

July 4, 2003

Wallen Pleads Guilty To Lesser Charges, To Pay $20,000 to CALGB, FDA

August 31, 1984